We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


International Genome Consortium Discovers New Genes that Control Blood Pressure

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "International Genome Consortium Discovers New Genes that Control Blood Pressure"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

In one of the largest genomics studies ever, an international research consortium that includes the National Institutes of Health has identified 29 genetic variations across 28 regions of the human genome that influence blood pressure.

This unprecedented effort brought together more than 230 researchers across six continents and scanned the genomes of over 200,000 people. The results will appear in the Sept. 11 edition of Nature.

"It is fitting that a global research group came together to provide new insight into a condition that affects over 1 billion people worldwide," said Susan B. Shurin, M.D., acting director of the NIH's National, Heart, Lung, and Blood Institute (NHLBI), which was part of the international consortium behind the study.

Shurin continued, "This is one of the most important studies of the genetics of high blood pressure to date and a significant step toward finding better therapies for it."

Sixteen of the 29 variations identified in the study were previously unrecognized. Six of the new variations were found in genes already suspected of regulating blood pressure; the other 10, which were found in unexpected locations, provide new clues into how blood pressure is regulated.

Individually, the genetic variations increased the risk of hypertension (high blood pressure) by only a tiny amount. For people with multiple variants, however, the effects were more significant.

The research team developed a blood pressure genetic risk score by combining variant combinations (with someone having many variants toward the top, and someone with very few at the bottom).

They found that people in the top 10 percent of the genetic risk score had blood pressure readings that were 5.8 mm/Hg and 3.7 mm/Hg higher for the systolic and diastolic values, respectively, than the lowest 10 percent risk score group.

Systolic refers to blood pressure as the heart is pumping blood, while diastolic refers to blood pressure between heartbeats.

In line with the increased values, hypertension also increased with risk score; 29 percent of people in the highest risk group had hypertension, compared to 16 percent in the lowest risk group.

The risk score was also a good indicator of hypertension complications such as increased thickness of heart chambers, heart failure, stroke, and coronary artery disease.

The risk score, however, was not a good indicator of the risk of kidney disease, another common hypertension-related problem.

The primary group of 200,000 participants was of European background and included subjects selected from several NHLBI study populations including the Framingham Heart Study (FHS).

The research consortium then followed up its analysis on 70,000 people of East Asian, South Asian, and African ancestry. The researchers found that the genetic risk score and several of the individual variants were associated with increased blood pressure in these ethnic groups as well.

"This study demonstrates the continuing value of large cohorts like Framingham, which started in 1948 and is still helping scientists uncover the genetics and biology of diseases today," said Daniel Levy, M.D., one of the co-leaders of this project and director of the FHS.

In addition to the NHLBI, the NIH's National Institute on Aging and the National Human Genome Research Institute also participated in and supported the study.